MedPath

Evaluation of Blood Gas Syringes

Completed
Conditions
Blood Gas Analyte Values
Registration Number
NCT01935284
Lead Sponsor
Smiths Medical, ASD, Inc.
Brief Summary

To assess the interchangeability and agreement between measurements from three blood gas syringes for the collection of blood for the analysis of multiple analytes as measured by differing manufacturers' multi-parameter analyzers.

Detailed Description

This is a prospective, randomized, post-market study using fresh blood for analysis that is obtained from healthy subject volunteers. Trained phlebotomists will collect blood samples from subjects after confirmation of eligibility criteria. Blood samples will be drawn to fill all study syringe types in a randomized order. Each syringe type will be drawn per subject to analyze each of the available blood parameters in duplicate using three different multi-parameter analyzers. The analytes tested will vary per analyzer capabilities. All blood draws and analyte testing will be performed at an independent laboratory. The study is to confirm that all of the syringes tested provide consistent readings when analyzed using the most common multi-parameter analyzers used in hospital laboratories.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  1. 18 years of age or older
  2. Willing and able to independently sign an English Informed Consent
  3. Have adequate veins for sampling blood from both right and left upper extremities
Exclusion Criteria
  1. Currently taking anti-coagulation medication
  2. Have a known bloodborne disease or bleeding tendency
  3. Have a known fear or adverse reaction to needles or blood
  4. Women who are pregnant or nursing

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Differences in analyte values obtained from three different blood gas syringes for each analyzer testedBlood analysis within 30 minutes of draw

For each of the analytes that are tested, the analyte values from each of the three (3) syringe types tested will be compared for each of the three (3) multi-parameter analyzers. Average values for each analyte per patient, syringe and analyzer will be used for the comparison of syringes for each analyzer.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Bionostics

🇺🇸

Devens, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath